Retour
Également cotée sous
NPNKF
OTC
Fourchette du Jour
8,07 €
8,71 €
Fourchette 52 Semaines
5,03 €
15,21 €
Volume
1
Moyenne 50J / 200J
8,65 €
/
6,75 €
Clôture Précédente
8,45 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,1 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | 13,9 | 3,8 |
| Net Margin % | 20,3 | 3,9 |
| Rev Growth 5Y % | 7,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 7,08% annually over 5 years — modest growth
Earnings grew 25,94% over the past year
ROE of 13,94% — decent returns on equity
Net margin of 20,32% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 32,77B in free cash flow
Croissance
Revenue Growth (5Y)
7,08%
Revenue (1Y)8,08%
Earnings (1Y)25,94%
FCF Growth (3Y)50,64%
Qualité
Return on Equity
13,94%
ROIC11,04%
Net Margin20,32%
Op. Margin22,94%
Sécurité
Debt / Equity
0,01
Current Ratio4,94
Interest Coverage253,54
Valorisation
P/E Ratio
0,07
P/B Ratio0,01
EV/EBITDA-1,37
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,08% | Revenue Growth (3Y) | 5,42% |
| Earnings Growth (1Y) | 25,94% | Earnings Growth (3Y) | 19,47% |
| Revenue Growth (5Y) | 7,08% | Earnings Growth (5Y) | 13,61% |
| Profitability | |||
| Revenue (TTM) | 160,23B | Net Income (TTM) | 32,56B |
| ROE | 13,94% | ROA | 11,48% |
| Gross Margin | 68,10% | Operating Margin | 22,94% |
| Net Margin | 20,32% | Free Cash Flow (TTM) | 32,77B |
| ROIC | 11,04% | FCF Growth (3Y) | 50,64% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 4,94 |
| Interest Coverage | 253,54 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 0,07 | P/B Ratio | 0,01 |
| P/S Ratio | 0,01 | PEG Ratio | 0,30 |
| EV/EBITDA | -1,37 | Dividend Yield | 0,03% |
| Market Cap | 2,17B | Enterprise Value | -50,34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 160,23B | 148,26B | 144,18B | 137,48B | 121,89B |
| Net Income | 32,56B | 25,85B | 22,81B | 24,99B | 19,54B |
| EPS (Diluted) | 120,82 | 95,96 | 84,68 | 92,74 | 72,53 |
| Gross Profit | 109,12B | 97,02B | 88,20B | 87,29B | 71,93B |
| Operating Income | 36,76B | 31,39B | 30,05B | 32,95B | 26,13B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 283,64B | 263,40B | 237,45B | 219,94B | 197,03B |
| Total Liabilities | 36,30B | 42,87B | 41,52B | 39,06B | 34,49B |
| Shareholders' Equity | 247,03B | 220,22B | 195,62B | 180,58B | 162,25B |
| Total Debt | 2,72B | 2,87B | 2,66B | 2,71B | 2,84B |
| Cash & Equivalents | 55,24B | 58,09B | 60,05B | 60,57B | 47,77B |
| Current Assets | 149,74B | 164,29B | 157,87B | 149,72B | 139,09B |
| Current Liabilities | 30,32B | 37,34B | 35,18B | 32,03B | 31,51B |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026